[Neurofibromatosis 1: recommendations for management]

Area of Science:

• Medical Science
• Genetics
• Neurology

Background:

• Neurofibromatosis 1 (NF1) is a genetic disorder requiring specific management strategies.
• Existing management guidelines may not fully address the complexities of NF1.
• A consensus among experts is crucial for developing effective NF1 care protocols.

Purpose of the Study:

• To establish expert-driven recommendations for the clinical management of neurofibromatosis 1.
• To synthesize current knowledge and expert opinion on NF1 patient care.
• To provide a framework for rational and coordinated follow-up of NF1 patients.

Main Methods:

• A literature review was conducted using Medline (1966-1999) and textbooks for terms including neurofibromatosis and NF1.
• Twenty French medical experts specializing in NF1 contributed to the development of recommendations.
• A consensual document was drafted based on extracted data and expert input.

Main Results:

• Annual clinical examinations are recommended for NF1 patients, unless complications arise.
• Routine screening investigations are generally not advised due to the low incidence of complications, which are typically symptomatic.
• Magnetic resonance imaging (MRI) is a potential exception for early detection of optic pathway gliomas in young children.

Conclusions:

• Coordinated follow-up in specialized multidisciplinary centers is recommended for optimal NF1 management.
• Patients with NF1 benefit from a rational management approach guided by expert consensus.
• The recommendations aim to standardize and improve the care provided to individuals with neurofibromatosis 1.